IsoPlexis Future Growth
Future criteria checks 2/6
IsoPlexis is forecast to grow earnings and revenue by 43.9% and 42.1% per annum respectively. EPS is expected to grow by 46% per annum. Return on equity is forecast to be -50.9% in 3 years.
Key information
43.9%
Earnings growth rate
46.0%
EPS growth rate
| Life Sciences earnings growth | 18.4% |
| Revenue growth rate | 42.1% |
| Future return on equity | -50.9% |
| Analyst coverage | Low |
| Last updated | 21 Mar 2023 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 72 | -28 | N/A | N/A | 1 |
| 12/31/2024 | 49 | -46 | N/A | N/A | 2 |
| 12/31/2023 | 30 | -56 | N/A | N/A | 2 |
| 12/31/2022 | 17 | -106 | -104 | -97 | N/A |
| 9/30/2022 | 19 | -98 | -118 | -109 | N/A |
| 6/30/2022 | 19 | -104 | -125 | -117 | N/A |
| 3/31/2022 | 19 | -102 | -132 | -104 | N/A |
| 12/31/2021 | 17 | -92 | -111 | -87 | N/A |
| 9/30/2021 | 15 | -76 | -90 | -67 | N/A |
| 6/30/2021 | 14 | -59 | -70 | -47 | N/A |
| 3/31/2021 | 12 | -41 | -33 | -31 | N/A |
| 12/31/2020 | 10 | -29 | -25 | -22 | N/A |
| 12/31/2019 | 8 | -15 | -17 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ISO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ISO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ISO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ISO's revenue (42.1% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: ISO's revenue (42.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ISO is forecast to be unprofitable in 3 years.